| scholarly article | Q13442814 |
| P2093 | author name string | William West | |
| Alexander M Walker | |||
| Carolyn C Cannuscio | |||
| Priscilla Velentgas | |||
| Douglas J Watson | |||
| P2860 | cites work | Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 |
| Nonsteroidal anti-inflammatory drug use and acute myocardial infarction | Q28193035 | ||
| Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program | Q28193105 | ||
| Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction | Q28214120 | ||
| Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
| A modified poisson regression approach to prospective studies with binary data | Q29615575 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study | Q29620671 | ||
| Management of acute coronary syndromes | Q33974144 | ||
| Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery | Q33985078 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
| Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis | Q38489191 | ||
| Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone). | Q43855350 | ||
| Association between naproxen use and protection against acute myocardial infarction | Q43999891 | ||
| COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease | Q44182620 | ||
| Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly | Q44316505 | ||
| Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults | Q44851038 | ||
| Risk of cardiovascular events and rofecoxib: cumulative meta-analysis | Q45175627 | ||
| Quasi-likelihood estimation for relative risk regression models | Q45200902 | ||
| Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. | Q45236722 | ||
| Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study | Q45260921 | ||
| Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes | Q47914147 | ||
| P433 | issue | 9 | |
| P921 | main subject | aspirin | Q18216 |
| inflammation | Q101991 | ||
| P304 | page(s) | 641-652 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
| P1476 | title | Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications | |
| P478 | volume | 15 |
| Q33363061 | Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example |
| Q28218005 | An economic model of long-term use of celecoxib in patients with osteoarthritis |
| Q28751133 | Bipolar disorder: candidate drug targets |
| Q38201752 | Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. |
| Q34584630 | Celecoxib: a review of its use in the management of arthritis and acute pain |
| Q33723762 | Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases |
| Q34592340 | Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials. |
| Q45842796 | Effect of prenatal exposure to diclofenac sodium on the male rat arteries: a stereological and histopathological study. |
| Q38990885 | Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression |
| Q36869571 | Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? |
| Q36835511 | Novel statistical tools for monitoring the safety of marketed drugs |
| Q36780451 | Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs compounded parenteral nutrition |
| Q30235369 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis |
| Q38436060 | Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease |
| Q44870828 | The role of p38 mitogen-activated kinase (MAPK) in the mechanism regulating cyclooxygenase gene expression in equine leukocytes. |
| Q33906348 | Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community |
Search more.